CIK 0001994702 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Kyverna Therapeutics, Inc.
Sign in to watch- Ticker
- KYTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831365441
- Phone
- 5109252492
- Business address
- 5980 HORTON STREET, SUITE 200, EMERYVILLE, CA
- Former names
- Kyverna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | Walker Karen Marie Chief Technology Officer | Sale 10b5-1 | −23,998 | $12.20 | $293K | 22,636 |
Page 1 of 1 · 1 trade